MedPath

Iron Deposits in the Pancreas by MRI Method of Dialysis Patients With Hemosiderosis Iatrogenic (ERDFP)

Not yet recruiting
Conditions
Iron Deposition
Iatrogenic Hemosiderosis
Dialysis
Interventions
Procedure: MRI
Registration Number
NCT05593068
Lead Sponsor
Ramsay Générale de Santé
Brief Summary

Recently, a multidisciplinary scientific conference proposed to consider iron overload in dialysis patients as pathological only in the event of demonstration of radiological (in MRI), pancreatic or cardiac ferric deposits.

In this context, the aim of the proposed scientific study is to demonstrate the presence of ferric deposits in the pancreas by T2\* MRI in dialysis patients with radiological hepatic iron overload, particularly in cases of moderate and severe iron overload.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
185
Inclusion Criteria
  • Male, female, over 18 years old
  • Patient on hemodialysis or peritoneal dialysis at the Claude Galien Private Hospital
  • Patient on dialysis who has undergone one (or more) abdominal MRI for iron quantification
  • Patient who has signed a non-objection form for the retrospective use of their MRI, medical and biological data for the purpose of scientific study
Exclusion Criteria
  • Patient who has signed a form to object to the use of their health data
  • Pregnant woman
  • Poor adherence to the dialytic technique
  • Severe cognitive impairment
  • Hepatic cirrhosis
  • Frank inflammatory syndrome or an active infectious disease
  • Genetic hemochromatosis and transfusion hemosiderosis of hemoglobinopathies and hematological diseases
  • Recent major bleeding (< 3 months)
  • Recent major surgery (< 3 months)
  • Transfusion dependence
  • Progressive malignant disease
  • Pacemakers incompatible with an MRI and metal heart valves

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Dialysed patients with suspicion of hepatic ironMRIPatients on dialysis at Claude Galien Private Hospital who had one or more MRI scans to monitor possible hepatic iron overload between May 2012 and March 2018.
Primary Outcome Measures
NameTimeMethod
Presence of pancreatic iron deposit1 day

Presence of pancreatic iron deposits as a function of hepatic iron level during iron overload in the dialysis patient will be evaluated from the pancreatic iron concentration measured by MRI and expressed by a T2\* value in ms.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital Privé Claude Galien

🇫🇷

Quincy-sous-Sénart, France

© Copyright 2025. All Rights Reserved by MedPath